Neuronetics schedules November 4 results for Neuronetics stock
Published on 10/25/2026 at 14:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQuarterly report and valuation
- On October 21, 2026, Neuronetics announced a November 4, 2026, third-quarter results release.
- Second-quarter 2026 revenue reached USD 41.57 million versus USD 40.17 million consensus.
- Market capitalization was USD 160.8 million on October 23, 2026, with a USD 0.80 to USD 3.44 52-week range.
Neuronetics (ISIN US64131A1051) reported USD 41.57 million in second-quarter 2026 revenue, above the USD 40.17 million consensus, according to MarketBeat. On October 21, 2026, GlobeNewswire reported that the company plans to publish third-quarter results before the market opens on November 4, 2026.
November 4 sets the next test
The scheduled release gives investors a defined checkpoint after a quarter in which revenue exceeded consensus by USD 1.40 million. That difference equals 3.49 percent of the USD 40.17 million estimate, while the company still reported a loss of USD 0.05 per diluted share against a consensus loss of USD 0.12.
Three milestones shape the setup
On August 11, 2026, Neuronetics reported second-quarter revenue of USD 41.57 million and a diluted loss of USD 0.05 per share, figures carried by MarketBeat. On October 6, 2026, the same source reported a five-broker consensus of Moderate Buy and an average price target of USD 4.67. On October 21, 2026, Neuronetics announced the November 4 reporting date through GlobeNewswire.
What does the report mean for losses?
The revenue beat provides a measurable growth marker, but profitability remains the sharper test. Neuronetics posted a second-quarter operating loss of USD 1.50 million and a net loss of USD 3.44 million, while operating cash flow was negative USD 1.01 million, according to the quarterly financial record for the period ended June 30, 2026.
Reporting date and Nasdaq context
The next substantiated date is November 4, 2026, for the third-quarter results release and the related conference call. GlobeNewswire said the call is scheduled for 8:30 a.m. ET, giving the announcement a clear pre-market timetable.
Nasdaq close and company scale
Neuronetics closed at USD 2.11 on Nasdaq on October 23, 2026. Its market capitalization was USD 160.8 million, and its 52-week range was USD 0.80 to USD 3.44 on that date.
The further course of trading is shown by the continuously updated real-time quote of Neuronetics stock.
Neuronetics stock facts
- Company: Neuronetics, Inc.
- ISIN: US64131A1051
- Ticker: STIM
- Primary exchange: Nasdaq
- Market capitalization: USD 160.8 million (as of October 23, 2026)
- 52-week range: USD 0.80-3.44 (as of October 23, 2026)
- Sector / Industry: Healthcare / Healthcare Equipment
Market context: Market report S&P 500.
